Novartis is a world leader in the research and development as well as manufacturing and marketing of products to protect and improve health and well-being. Our goal is to discover, develop and successfully market innovative products to cure diseases, to ease suffering and to enhance the quality of life. We also want to provide a return to shareholders that reflects our performance and to adequately reward those who invest ideas and resources in our company.
Created in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis is organized into three divisions:
- Pharmaceuticals, which comprises our activities in prescription pharmaceuticals;
- Sandoz, which comprises our activities in generic prescription drugs; and
- Consumer Health, which comprises our activities in Over-the-Counter (OTC) self-medication products, medical nutrition, animal health, infant & baby foods, and lens and vision care.